< Back to all clusters
[HEALTH] · United States, Germany · 9 sources

started · updated

US cancer centers ration Ifosfamid due to drug shortage

Cancer centers across the United States have begun rationing the chemotherapy drug Ifosfamid due to a severe supply shortage. Because there is no direct therapeutic substitute, medical organizations including the American Society of Clinical Oncology and the Association for Clinical Oncology have issued guidelines for a three-stage rationing system. This system requires doctors to prioritize patients with the most urgent needs, such as children with specific sarcomas and patients with lymphoma or testicular cancer.

The shortage originated after a production facility in Germany, commissioned by Baxter, halted operations following an inspection. While alternative manufacturers like Fresenius Kabi and Hikma have implemented supply contingencies, their deliveries are expected to be insufficient to meet US demand in the coming weeks. The shortage is projected to last at least until October, though the timeline for full production recovery remains uncertain.

Separately, a massive phishing campaign is targeting approximately 190 million MyChart users worldwide. The software developer Epic Systems warned that cybercriminals are sending fraudulent emails and SMS messages disguised as medical test results or health rewards to trick patients into installing malware. The campaign exploits the high brand trust of the MyChart platform, which is used by 44 percent of the healthcare market.

Entities

American Society of Clinical Oncology · Association for Clinical Oncology · Baxter · Epic Systems · Germany · Ifosfamid · MyChart · Tallahassee Memorial HealthCare · Tampa General Hospital · United States

Claims

What the coverage asserts, and how many sources carry each claim.